In today's Just The Facts..
Anteris Technologies has announced strong one-year clinical results for its DurAVR transcatheter heart valve in small annuli patients. The data showed excellent blood flow, no valve-related mortality, and minimal leakage.
Elixir Energy has formed a joint venture and completed drilling at Diona-1. The well is now heading into stimulation and flow testing, with tie-in to nearby infrastructure possible this quarter. Elixir is also gearing up to drill Lorelle-3 in January using a top-tier rig.
Terra Metals has intersected multiple new sulphide zones at its Dante Project, pointing to a large-scale magmatic system. Assay results are pending and due in the next three months.
Orthocell has appointed MontsMed as its exclusive distributor for Remplir™ in Hong Kong, marking its entry into a US$3.5 billion market. With regulatory approval secured, the first surgeries and sales are expected soon, expanding the company’s reach across Asia.
#ASX #ASXNews #AnterisTechnologies #ElixirEnergy #TerraMetals #Orthocell #BiotechStocks #EnergyStocks #MiningStocks